DSTL - ETF AI Analysis

Top Page

Distillate US Fundamental Stability & Value ETF (DSTL)

Rating:72Outperform

Price Target:―

DSTL, the Distillate US Fundamental Stability & Value ETF, earns a solid overall rating driven by high-quality holdings like Merck and Salesforce, which benefit from strong financial performance, positive earnings outlooks, and strategic growth initiatives such as pipeline advancements and AI-focused investments. Other key positions like Qualcomm and T-Mobile also support the fund through robust results and constructive long-term prospects, though some holdings such as Booking Holdings and Altria introduce risks related to high leverage, valuation concerns, and challenges in certain business segments. The fund is also exposed to the risk that several major holdings face technical or valuation headwinds, which could add volatility despite their strong fundamentals.

Positive Factors

Large Asset Base

The fund manages a sizable pool of assets, which can support trading liquidity and stability for investors.

Broad Sector Diversification

Holdings spread across technology, health care, industrials, consumer sectors, and more help reduce the impact of weakness in any single industry.

Solid Year-to-Date Performance

The ETF has delivered positive returns so far this year, showing it has held up reasonably well in the current market.

Negative Factors

Weakness in Top Holdings

Many of the largest positions have shown weak performance this year, which can drag on the fund’s future returns if the trend continues.

Higher-Than-Index Expense Ratio

The fund’s fee is noticeably higher than many broad U.S. stock index ETFs, which can slowly reduce net returns over time.

Heavy U.S.-Only Exposure

With almost all assets in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market’s fortunes.

DSTL vs. SPDR S&P 500 ETF (SPY)

AUM1.84B

RegionNorth America

Expense Ratio0.39%

Beta0.72

IssuerDistillate

Inception DateOct 24, 2018

Dividend Yield1.26%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume81,880

30 Day Avg. Volume101,627

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

71.44

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering101

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DSTL Summary

DSTL is the Distillate US Fundamental Stability & Value ETF, which invests in large U.S. companies that the managers believe are financially strong and reasonably priced. It does not track a set index, but instead selects stocks based on stability and value. The fund holds well-known names like AbbVie and Adobe, and spreads money across many sectors, including technology, health care, and industrials. Someone might invest in DSTL to seek steady growth from high-quality U.S. companies while staying diversified. A key risk is that its stock prices can still go up and down with the overall U.S. market.

How much will it cost me?The expense ratio for the Distillate US Fundamental Stability & Value ETF (DSTL) is 0.39%, which means you’ll pay $3.90 per year for every $1,000 you invest. This is slightly higher than the average for passively managed ETFs because DSTL uses a strategic, rules-based approach to select financially stable and value-oriented large-cap U.S. companies.

What would affect this ETF?DSTL's focus on financially stable U.S. large-cap companies, particularly in sectors like healthcare and technology, positions it to benefit from advancements in medical innovation and tech growth. However, rising interest rates or economic slowdowns could negatively impact consumer spending and corporate earnings, affecting sectors like consumer cyclical and industrials. Regulatory changes in healthcare or technology could also influence the ETF's performance.

DSTL Top 10 Holdings

DSTL leans heavily into U.S. large caps with a tilt toward tech and health care, and that mix is creating a tug-of-war in performance. Defensive health care names like Merck and AbbVie are acting as steady anchors, helping cushion volatility. On the other side, once high-flying software and IT services names such as Salesforce, Adobe, and Accenture have been losing steam, weighing on returns. Qualcomm and Booking show more mixed signals, leaving the fund driven by a value-flavored tech story that’s currently battling some growth fatigue.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ABBV	AbbVie	2.67%	$49.27M	$351.47B	2.62%	66 Neutral
MRK	Merck & Company	2.58%	$47.60M	$276.38B	32.50%	80 Outperform
CRM	Salesforce	1.96%	$36.11M	$145.74B	-32.17%	80 Outperform
QCOM	Qualcomm	1.93%	$35.58M	$158.82B	1.79%	80 Outperform
BKNG	Booking Holdings	1.86%	$34.20M	$140.27B	-9.24%	63 Neutral
UBER	Uber Technologies	1.83%	$33.66M	$152.03B	-2.63%	74 Outperform
TMUS	T Mobile US	1.72%	$31.76M	$209.13B	-22.82%	76 Outperform
CMCSA	Comcast	1.70%	$31.24M	$98.45B	-18.54%	74 Outperform
ADBE	Adobe	1.60%	$29.53M	$99.21B	-35.08%	80 Outperform
CI	Cigna	1.53%	$28.10M	$72.68B	-15.60%	72 Outperform

DSTL Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price―

Price Trends

50DMA

59.34

Negative

100DMA

59.52

Negative

200DMA

58.06

Positive

Market Momentum

MACD

0.19

Negative

RSI

51.41

Neutral

STOCH

12.50

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DSTL, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 59.04, equal to the 50-day MA of 59.34, and equal to the 200-day MA of 58.06, indicating a neutral trend. The MACD of 0.19 indicates Negative momentum. The RSI at 51.41 is Neutral, neither overbought nor oversold. The STOCH value of 12.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DSTL.

DSTL Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DSTL	―	―	$1.84B	0.39%	72 Outperform
PVAL	―	―	$9.88B	0.55%	72 Outperform
JAVA	―	―	$6.35B	0.44%	71 Outperform
DFLV	―	―	$5.80B	0.21%	73 Outperform
FELV	―	―	$2.84B	0.18%	72 Outperform
SEIV	―	―	$1.27B	0.15%	72 Outperform

Performance Comparison

DSTL

Distillate US Fundamental Stability & Value ETF

59.29

7.40

14.26%

PVAL

Putnam Focused Large Cap Value ETF

―

JAVA

JPMorgan Active Value ETF

―

DFLV

Dimensional US Large Cap Value ETF

―

FELV

Fidelity Enhanced Large Cap Value ETF

―

SEIV

SEI Enhanced U.S. Large Cap Value Factor ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents